Valentin Fuster

Public Health, Environmental and Occupational Health · 2000–2020

A researcher in the Science corpus: 21 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Public Health, Environmental and Occupational Health — 53 citations into it
• Pediatrics, Perinatology and Child Health — 36 citations into it
• Nutrition and Dietetics — 14 citations into it

Whom Valentin Fuster trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Adam Drewnowski
2. Roya Kelishadi
3. Colin D Mathers
4. Anoop Misra
5. Christopher J. L. Murray
6. B. Galobardes
7. Youfa Wang

Papers from Valentin Fuster's perspective

Ordered by how strongly the researchers Valentin Fuster trusts endorse each paper. Same corpus, a different order for every researcher.

1. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. (Journal of Clinical Investigation)
2. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: the Bogalusa Heart Study. (Pediatrics)
3. Enhanced Peroxynitrite Formation Is Associated with Vascular Aging (Journal of Experimental Medicine)
4. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission (Clinical Infectious Diseases)
5. Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis (Arteriosclerosis, Thrombosis and Vascular Biology)
6. R: A language and environment for statistical computing.
7. Particulate air pollution induces progression of atherosclerosis. (Journal of the American College of Cardiology)
8. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. (New England Journal of Medicine)
9. Exposure to traffic and the onset of myocardial infarction. (New England Journal of Medicine)
10. Pathology of the vulnerable plaque. (Journal of the American College of Cardiology)

Their papers

• Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection (2020) — 668 citations
• AKI in Hospitalized Patients with COVID-19. (2020) — 606 citations
• The Global Burden of Cardiovascular Diseases and Risks: A Compass for Global Action. (2020) — 710 citations
• Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19 (2020) — 875 citations
• The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. (2019) — 1,278 citations
• Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data. (2018) — 619 citations
• Clonal hematopoiesis and risk for atherosclerotic cardiovascular disease (2017) — 2,178 citations
• Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting (2017) — 491 citations
• Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) — 1,197 citations
• In Vivo Diagnosis of Plaque Erosion and Calcified Nodule in Patients with Acute Coronary Syndrome by Intravascular Optical Coherence Tomography (2013) — 793 citations
• Cholesterol efflux and atheroprotection: Advancing the concept of reverse cholesterol transport (2012) — 911 citations
• Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health (2010) — 668 citations
• Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. (2005) — 839 citations
• Atherothrombosis and high-risk plaque: part I: evolving concepts. (2005) — 833 citations
• Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. (2004) — 598 citations
• Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability (2004) — 656 citations
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. (2003) — 893 citations
• AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) — 693 citations
• Coronary artery disease: pathogenesis and acute coronary syndromes. (2001) — 763 citations
• Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. (2000) — 921 citations